Full Breakdown
Senate AI Caucus Introduces the Homestake AI Act to Accelerate Disease-Curing Research
7/16/2026, 1:28:15 AM
Core Proposal
Senators Mike Rounds (R-SD) and Martin Heinrich (D-NM), co-chairs of the Senate AI Caucus, unveiled the Homestake AI Act. The bill would task the Department of Energy with establishing a program to collect organisms from “unique locations” – such as extreme temperatures or pressures – and compile an artificial-intelligence-driven database. Researchers could then sequence, catalog, and analyze these specimens to identify molecular components that might treat or cure diseases including cancer, Alzheimer’s, Parkinson’s, diabetes and other conditions.
Legislative Context
The measure is the first product of the Senate AI Caucus’s broader initiative to speed U.S. scientific research and development. It builds on the administration’s Genesis Mission, a federal effort to promote AI-enabled discovery. The bill’s name references the historic Homestake underground laboratory in South Dakota, where deep-earth research has long been conducted.
Key Sponsors
- Sen. Mike Rounds – Republican of South Dakota, longtime advocate for AI adoption in health and science.
- Sen. Martin Heinrich – Democrat of New Mexico, co-chair of the Senate AI Caucus and proponent of AI-driven biomedical research.
Why It Matters
Proponents argue that organisms thriving in extreme environments often possess unique biochemical adaptations that could inspire novel therapeutics. The legislation cites the Gila monster as a precedent: a hormone discovered in its venom helped develop GLP-1 drugs such as Ozempic for diabetes. By systematizing the search for similar “secret” compounds, the act aims to keep the United States at the forefront of medical innovation while potentially reducing long-term health-care costs.
Official Statements & Responses
Sen. Rounds emphasized the urgency of federal support, blaming stalled appropriations for delayed progress. He linked the bill to the Genesis Mission, suggesting that coordinated AI resources could translate organismal discoveries into treatments more rapidly. Sen. Heinrich highlighted the bill’s role in ensuring comprehensive, AI-assisted cataloging of biodiversity, framing it as essential to maintaining America’s leadership in scientific innovation and saving lives.
Criticism & Opposition
No explicit criticism appears in the provided sources. The discussion centers on bipartisan enthusiasm for accelerating disease-curing research through AI.
Verbatim Quotes
- “We should be within two years right now of actually curing the vast majority of cancers,” — Mike Rounds, Senator
- “There’s no reason for it except obstinance, and not an understanding of what we’re losing. Time is valuable.” — Mike Rounds, Senator
- “If we invested appropriately and focused on it, we would cure the vast majority of cancers in the next five years.” — Mike Rounds, Senator
- “usually hold an interesting secret to doing so.” — Mike Rounds, Senator
- “We need to leave no stone unturned in the race to discover cures and treatments for cancer, diabetes, and dementia,” — Martin Heinrich, Senator
- “This is how we keep America at the forefront of scientific innovation while saving lives.” — Martin Heinrich, Senator
Expected Outcomes
If enacted, the Department of Energy would launch a coordinated effort to harvest, sequence, and AI-analyze specimens from harsh habitats. The resulting database could accelerate target identification for drug development, potentially shortening the timeline from discovery to clinical trials for multiple high-impact diseases.
